"Apple Exceeds Emini Volume" questions whether AAPL shares had a "blow-off top" early in the week.
"Apple's Price Gains Distort the Market" highlighted the outsized role of Apple on the broader market.
Plus, my Apple view was summarized in Barron's.
My Trade of the Week shorting the iShares Nasdaq Biotechnology (IBB) at an average cost of $338.85 was principally based on my cautious market view and an overbought view of the Index. The index closed slightly higher than my cost basis.
Based on comments, my closing post, "See Ya in the Funny Papers," got a lot of interest in my Diary.
On Tuesday, I delivered a negative analysis of Wal-Mart (WMT); the shares were down by about $1 per share in Wednesday's trading.
Fed Chair Janet Yellen's second day of testimony was anti-climactic. Again, I felt she was neither hawkish nor dovish on Tuesday, just talking gibberish.
This morning, S&P 500

Palo Alto numbers boosted at Oppenheimer

Feb 26, 2015 | 7:10 AM EST

Shares of PANW now seen reaching $150, according to Oppenheimer. Estimates also upped, following the latest channel checks. Outperform rating.